Sign in to view more
Systematic bias between blinded independent central review and local assessment: literature review and analyses of 76 phase III randomised controlled trials in 45 688 patients with advanced solid tumour.
Evaluation bias in objective response rate and disease control rate between blinded independent central review and local assessment: a study-level pooled analysis of phase III randomized control trials in the past seven years.
Exon 19 deletion association with progression-free survival compared to L858R mutation at exon 21 in treatment with first-line EGFR-TKIs: A meta-analysis of subgroup data from eight phase III randomized controlled trials.
Fruitful steps in the prevention of chemotherapy-induced nausea and vomiting (CINV) over the past 30 years: A historical comparison of patients enrolled in clinical trials during different antiemetic times.
142TiPA prospective multi-center study to investigate the EGFR-TKI resistance profile, treatment algorithm and clinical outcome in Chinese patients with advanced EGFRm+ NSCLC who have received prior first generation EGFR TKI (PRECENT study, CCTC-1601, NCT02988141)
Icotinib versus vinorelbine/platinum as adjuvant therapy in stage II-IIIA non-small cell lung cancer with EGFR-mutations: A multicenter, randomized, positive-controlled, phase 3, indication-expanding study (EVIDENCE, CCTC-1501).
430PDirect comparison of diagnostic accuracy between autofluorescence bronchoscopy (AFB) and AFB combined with white light bronchoscopy (AFB + WLB) for lung cancer and precancerous lesions: a systematic review and meta-analysis